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management and prevention of deep tissue injuries (DTIs)
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risk of DTI.
In doing so, however, the Group recognises that much remains to 
be learnt about DTI. Development of the document began with 
a day-long meeting and was followed by extensive review of the 
resulting text before production of this final document.
By explaining current understanding of the mechanisms involved 
in the development of DTI and describing how to recognise, 
treat and prevent DTI, the document aims to improve diagnosis, 
management, prevention and reporting of DTIs in the UK.
The chart ‘Deep tissue injury (DTI) - an overview’ (page 1) 
summarises the content and guidance provided in this document 
and links to the appropriate pages.
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A DTI is a type of pressure ulcer (PU); occurs most commonly at the heels, sacrum and buttocks  
(including the ischial area)
■n In light-toned skin often presents as an area of non-blanching purple or maroon skin and in dark-toned skin, as 
discolouration or lighter/darker skin
■n May feel firmer or softer (‘boggy’ or ‘mushy’) and warmer or cooler than surrounding tissues
■n 24–48 hours later, the area may look dry; the epidermis may peel or a shallow blister may form that may or may not break open
■n Blisters can be filled with a dark liquid and look like blood blisters; edges of the blister will be non-blanching
■n May develop a hard, blackened surface (eschar); when this sloughs or is debrided a deep wound may be revealed
■n May deteriorate rapidly to an open wound, resolve before the skin breaks or remain static
A DTI results from external application of a mechanical load (pressure), to the skin and subcutaneous tissues over a 
bony prominence such as the heel
■n The load causes tissue necrosis by producing direct structural damage to cells and by reducing blood flow and 
drainage of fluids and waste products. Return of blood flow may add to the tissue damage (reperfusion injury)
■n DTIs start at the bone:tissue interface and develop from the ‘inside out’
■n As a result, a DTI may not become apparent for 24–72 hours after the mechanical loading event that caused it  
DTIs share many risk factors with PUs, e.g. restricted mobility, immobility, altered posture, poor blood flow to tissues due to heart 
or lung disease, smoking, diabetes, reduced sensation, incontinence, increased age, poor nutrition and poor general health
■n Factors particularly increasing risk of a DTI are restricted mobility, immobility, impaired sensation and reduced tissue tolerance
■n Patients at increased risk include those with a sudden unexpected period of reduced mobility due to collapse, fracture or 
cerebrovascular accident, those on an emergency department trolley or undergoing prolonged surgery, those receiving intensive 
care, acute care or long-term care, and those that are transferring between facilities or transitioning from being bed bound to 
sitting in a chair
Several conditions other than DTI present with discoloured, purple or maroon skin
■n Exclude Category 1 or 2 PU, bruise, haematoma, blood blister, skin tears and incontinence-associated dermatitis 
before diagnosing a DTI
■n Conduct assessment, management and prevention of DTI in the context of the principles of mental capacity and consent
■n Even if the diagnosis is unclear, refer as necessary and at the same time treat as for a DTI 
■n Undertake structured formal assessment, including full skin inspection and PU risk assessment
■n PU risk assessment tools should be used alongside skin inspection and clinical judgement
■n Use a structured wound assessment to assess the DTI 
■n Document assessment; report according to local guidelines for incident reporting
Define objectives, remembering that sometimes other care needs may take priority
■n Optimise patient condition: nutrition and hydration, management of comorbidities
■n Offload the DTI, i.e. ensure no contact with a support surface and no mechanical load
■n Reposition regularly and use pressure redistribution support surfaces
■n Manage pain, including pain due to repositioning or wound care
■n Keep patient clean and dry; moisturise dry skin
■n If the skin is broken or there is an open wound, cleanse and cover with an appropriate dressing
■n Monitor and regularly reassess 
■n Refer as appropriate, e.g. to a tissue viability service,  if the DTI deteriorates rapidly or has not improved within two weeks
■n Educate the patient, family and carers
■n Document objectives and management strategies
Identify patients at risk by recognising risk factors (see above ‘Who is at risk of a DTI?’), using formal PU risk assessment 
tools and regularly inspecting skin
■n Clinical judgement should be used in combination with PU risk assessment tools
■n When a patient is recognised to be at risk of DTI:
- Perform a holistic assessment
- Reduce risk of tissue damage, e.g. offload, implement regular repositioning and use pressure redistribution support surfaces, 
while considering all of the patient’s needs
- Optimise patient condition: nutrition, management of comorbidities, pain management
- Educate the patient, family and carers
- Monitor and reassess risk of pressure damage and effectiveness of prevention regimen
■n Document assessment and prevention strategies
What is a 
DTI?
Pages 
3-5
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The challenges of DTI
A deep tissue injury (DTI) is a type of subcutaneous tissue damage that results from an 
externally applied mechanical load (pressure). Recognition that DTIs have features distinct 
from pressure ulcers (PUs) led to DTIs being added in 2009 to the international classification 
of pressure ulcers (PUs) produced by the European Pressure Ulcer Advisory Panel and National 
Pressure Ulcer Advisory Panel (EPUAP/NPUAP, 2009). A DTI is not always associated with 
broken skin and does not always become the open wound often defined as a PU. However, DTIs 
do have the potential to develop into large, deep wounds with significant tissue loss that have 
serious consequences for patients and healthcare systems (Peart, 2016).
The formalisation of DTIs as a distinct category within PU classification is relatively recent. This, 
along with recent changes in PU terminology in some parts of the world (Box 1), and variations 
across the UK’s healthcare systems in requirements for reporting and data collection, has caused 
confusion. It is likely that DTIs are under-reported because they are not always easy to recognise, 
particularly in the early stages, and may be miscategorised or not reported. In addition, some 
reporting systems do not include DTI or delay recording of the tissue damage until classification 
as one of the main PU categories is made.
Box 1. Terminology issues
Suspected deep tissue injury (sDTI) or deep tissue injury (DTI)?
When DTIs were first included in the international classification for PUs, the term DTI was preceded by the word suspected 
(abbreviated to sDTI) partly because of a lack of understanding of the condition and its relationship to other types of 
pressure-related damage (EPUAP/NPUAP, 2009). However, the pathophysiology of DTIs is now much better understood, 
and it is recognised that externally applied mechanical loads, such as pressure and shear, can give rise to DTIs and PUs in 
different ways (Oomens et al, 2015). For this reason, and because of other concerns over the use of the word, the recently 
updated PU classification produced by the NPUAP has dropped the ‘suspected’ preceding DTI (Edsberg et al, 2016).
The Expert Working Group also proposes that ‘suspected’ is omitted before DTI in the UK to remove any 
misunderstanding about the existence of DTI as a distinct condition and to encourage appropriate reporting, 
management and prevention
Pressure ulcer (PU) or pressure injury (PI)?
In 2016, the NPUAP decided to replace the term ‘pressure ulcer’ (PU) with ‘pressure injury’ (PI) (Edsberg et al, 2016). This brought 
NPUAP terminology in line with that used in countries covered by the Pan Pacific Pressure Injury Alliance (PPPIA) (Australia, 
Singapore, Hong Kong and New Zealand) (AWMA, 2012). Reasons for this change included the desire to emphasise both the 
preventable nature of many PUs and the fact that not all PUs represent open wounds. However, there are concerns with the use 
of the term ‘injury’ because it implies a very acute event leading to the tissue damage, even though it is known that the damage 
associated with PUs may take some time to develop (Bader & Schoonhoven, 2016; Ousey et al, 2017a). Indeed, the time element 
underpins the rationale for repositioning in the prevention of PUs. In addition, there are concerns that using the word ‘injury’ might 
be seen to imply that healthcare providers have caused the injury; a concern that has also been raised in the US (Mrdjenovich et al, 
2016; NPUAP Position Statement, 2017). Finally, replacing the word ‘ulcer’ removes alignment with other wounds such as diabetic 
foot ulcers (DFUs) and venous leg ulcers (VLUs). This is particularly unfortunate in the case of DFUs, which often share some of 
the same aetiological mechanisms as PUs (Vowden & Vowden, 2015).
In common with a recent NHS Improvement consensus meeting that voted to use ‘pressure ulcer’ in England, the Expert 
Working Group recommends retaining the term ‘pressure ulcer’ (PU) in the UK
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Defining DTI
DTI is a type of subcutaneous tissue damage, affecting muscle where present, that originates close 
to bone and is the result of a mechanical load, such as pressure, applied to the skin. Box 2 contains 
the definition of DTI from the most recent (2014) NPUAP/EPUAP/PPPIA PU prevention and 
management guidelines. As noted in Box 1 (page 2), the Expert Working Group recommend using 
‘deep tissue injury’ and omitting ‘suspected’.
RECOGNISING DTI
The appearance of a DTI on presentation depends on when it is recognised in the time course 
of DTI development. As the name suggests, DTI starts deep within tissue and does not usually 
become apparent until about 24–72 hours after the event that caused the tissue damage (Black 
et al, 2016). Such events include lying immobile on a hard surface, e.g. on the floor after a fall that 
has resulted in unconsciousness or that is due to a stroke, or experiencing a period of poor tissue 
perfusion, e.g. during cardiothoracic surgery. In keeping with pain being a predictor of PUs (Smith 
et al, 2017), conscious and sensate patients may complain of pain before the appearance of the 
physical signs of DTI. See pages 9-10 for more detail on risk factors for DTI.
In patients with light-toned skin, DTI presents about 24–72 hours after initiation as a demarcated 
area of purple or maroon skin, often likened to a bruise. The purple or maroon area may be 
surrounded by an area of erythema (Figure 1). The discoloured area and erythema are non-
blanchable (Box 3, page 4) (Black et al, 2016).
When palpated, the affected area may feel:
■n Firmer or hardened (indurated) due to stiffening of dead or dying muscle tissue or
■n Softened (‘boggy’ or ‘mushy’) as the damaged tissue starts to break down and/or
■n Warmer or cooler than surrounding areas (Gefen, 2009).
In patients with dark-toned skin, the skin of affected areas may be darker or lighter, and palpation 
to detect changes in tissue texture or temperature is particularly important (Black et al, 2016). 
A retrospective review of patients with darkly pigmented skin found that the most commonly 
described presentation of DTIs was purple discolouration of intact skin (Sullivan, 2014).
Patients who are conscious and have sensation in the affected area may complain of 
discomfort or pain, and/or find palpation uncomfortable or painful
When assessing the temperature of the skin, it is important to consider whether the area has been 
in contact with or covered by bedding or clothing or has been exposed (i.e. it is warmer or cooler for 
extrinsic reasons), the ambient temperature, and the temperature of the assessor’s hands.
Figure 1: DTI on side of foot 
The darkened purple/maroon 
area is surrounded by an area 
of non-blanchable erythema.
“Purple or maroon 
localized area of 
discolored intact skin 
or blood-filled blister 
due to damage of 
underlying soft tissue 
from pressure and/or 
shear. The area may be 
preceded by tissue that 
is painful, firm, mushy, 
boggy, warmer or 
cooler as compared to 
adjacent tissue.”
Box 2. NPUAP/
EPUAP/PPPIA 
definition of 
suspected DTI 
(NPUAP/EPUAP/
PPPIA, 2014)
•
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It is important to palpate the skin and subcutaneous tissues of any area that may have 
tissue damage
After a further 24–48 hours, the outer layer of the skin of the affected area may appear dry, start 
to peel or form a shallow blister (known as epidermal lift or sloughing). The full thickness of the 
skin may also lift or blister, and breaks in the skin can occur to reveal a purple, maroon, black or 
white wound bed (Black et al, 2016). In patients with dark-toned skin, blistering and skin breaks 
may be the first signs noticed of a DTI (Sullivan, 2014). Blisters may become filled with liquefied 
necrotic tissue and look like blood blisters.
Eventually a hard, blackened surface (eschar) may develop. When this finally sloughs or is 
debrided it will reveal the extent of the tissue damage and possibly a deep open wound. In some 
cases, sloughing of the eschar reveals intact or healed skin.
Although the appearance of DTI is often described as a bruise, it should be noted that a DTI 
does not go through the colour changes typical of a bruise as it resolves
NATURAL HISTORY AND EVOLUTION OF DTI
The potential evolution of a DTI is illustrated in Figure 2, page 5. Although full clarification of the 
natural history of DTIs and the factors that influence it is still to be established, it is clear that the 
outcome is variable. Some DTIs can deteriorate very rapidly to become large, deep open wounds 
despite best practice management. However, not all DTIs evolve or deteriorate. A proportion of 
DTIs will remain static for quite some time (anecdotally up to several months) or will resolve 
without forming an open wound (Richbourg et al, 2011). 
In the experience of the Expert Working Group, when resolution occurs it is often within 
7–10 days of diagnosis of the DTI
Currently, it is not known what proportion of DTIs resolve or whether there are indicators that 
could be used to predict which DTIs will resolve. A two-year study that followed 128 DTIs for an 
average of 6 days found that 37.5% of DTIs had resolved at the end of follow-up (Sullivan, 2013).
DTIs that resolve or remain static need continued care and monitoring to ensure the area is not 
exposed to further mechanical loading and to prevent repeated damage or extension of the injury
•
•
•
•
Gentle pressure is applied to the discoloured or reddened 
skin for three seconds using either a finger or a clear  
plastic device.
a) Blanchable erythema – application of pressure will push 
blood away from the area that has been pressed turning 
it paler than the surrounding skin (see photograph).
b)  Non-blanchable erythema – if the blood flow to the 
area being tested has been damaged, the application 
of pressure will not make the skin become paler and it 
will remain discoloured or reddened. Non-blanchable 
erythema indicates tissue damage.
Box 3. Testing for non-blanchable erythema (NPUAP/EPUAP/PPPIA, 2014)
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LOCATION OF DTI
An analysis of US data from a large international pressure ulcer prevalence survey undertaken in 2006–
2009 found that DTIs accounted for about 9% of all PUs. The study also found that 41% of the DTIs 
occurred at the heel, 19% over the sacrum and 13% on the buttocks (VanGilder et al, 2010) (Figure 3).
A more recent analysis of hospital-acquired DTIs recorded over a two-year period (2010–2012) in one 
US hospital, reported the coccyx, heels and buttocks to be the most commonly affected sites. This study 
also reported DTIs to have occurred in relation to medical devices, and at the sacrum, intergluteal area, 
trochanter and ischium (Tescher et al, 2017).
The heels are thought to be particularly at risk of DTI because the underlying bony prominence (the 
calcaneus) has a small radius of curvature, i.e. is relatively pointed, and the layer of tissue overlying the 
bone is relatively thin (Salcido et al, 2011). This means that the intensity of a mechanical load applied to 
the heel can be high.
The location of a DTI will depend on the position of the patient. For example, in a patient who is sitting 
upright in a chair, DTI may occur under the ischial tuberosities, and in a patient who is sitting in bed with 
the head of bed elevated, DTI may occur over the sacrum. Similarly, a patient who has been lying on the 
floor after a fall or collapse due to acute illness may have evidence of damage at points that have been 
in contact with the floor. DTI may also occur under medical devices such as casts, splints, oxygen face 
masks or elastic bandaging (Tescher et al, 2017). 
DTIs are most commonly found at the heels, sacrum and buttocks, but may occur in any 
location where prolonged pressure is applied, including under medical devices
As DTIs can occur at anatomical sites where PUs may occur, pressure-related damage, 
including any related to a medical device, should be carefully assessed to determine whether 
the damage is a DTI or a PU
Figure 2: Potential evolution 
of a DTI
Figure 3: Sites of DTI 
occurrence (VanGilder et al, 
2010)
•
•
Heels
Sacrum
Buttocks
Other
41%
19%
27%
Resolves
*Evolution may include:
+/- Enlargement (increased area)
+/- Darkening
+/- Break in the skin (epidermal lift or sloughing)
+/- Blister (may or may not break)
+/- Further tissue breakdown
N.B. A significant proportion of DTIs do not progress 
to skin breakdown and, though they may darken and 
enlarge, can resolve.
Remains staticEvolves*
DTI
Discoloured, maroon or 
purple demarcated area 
of skin
13%
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PUs and DTIs occur because of tissue damage caused by the application of a mechanical load 
(Box 4) to the skin, subcutaneous tissues and muscle. In general, higher mechanical loads will result 
in tissue damage more quickly than lower loads (Figure 4).
MAIN MECHANISMS
A mechanical load can have several effects that may ultimately damage tissue and cause tissue 
breakdown and cell necrosis (Figure 5, page 7). The two main mechanisms involved are:
■n Structural damage – The mechanical load has a direct effect on tissue cells, damaging cell 
membranes and disrupting internal cell structure to cause cell death. In vitro and animal studies 
have shown that this type of damage can occur within tens of minutes of application of the 
mechanical load and certainly much more rapidly than the damage caused by ischaemia 
(Gawlitta et al, 2007; Oomens et al, 2015).
■n Ischaemia – The mechanical load can compress capillaries causing partial or complete occlusion. 
This reduces the delivery of oxygen and nutrients to tissues. If the rate of delivery is below the 
physiological demands of the tissues, ischaemia will occur. If the ischaemia is sustained for long 
enough and/or at high enough levels, tissue death can occur due to a change in metabolism and 
the accumulation of waste products. Generally, ischaemia takes a few hours to produce tissue 
damage, and muscle is more susceptible to ischaemia than skin (Agam & Gefen, 2007; Oomens 
et al, 2015).
Causes of DTI
Figure 4: Effects of 
magnitude of mechanical 
load and time on likelihood 
of tissue damage (adapted 
from Stekelenberg et al, 
2008; Gefen et al, 2008; 
International Review, 
2010)
■n Mechanical load – a generic term that covers all forces, including pressure and shear, applied to the skin 
and subcutaneous tissues, e.g. muscle
■n Pressure – results from the application of a force perpendicular (i.e. at right angles) to the surface of the 
skin. The pressure compresses the tissues and can distort or deform the skin, subcutaneous tissues and 
muscle. Tissue distortion is likely to be greatest when pressure is applied over a bony prominence
■n Shear – causes layers of body tissues to move relative to each other and may occur:
a) Superficially – e.g. as a result of a force applied parallel (tangentially) to the surface of the skin 
b) More deeply (internally) – e.g. as the result of deformation of skin and muscle when pressure is applied 
over a bony prominence
Box 4. Mechanical load, pressure and shear in the context of PUs and DTIs (International Review, 
2010; Gefen et al, 2013) 
Threshold for tissue damage:
✖■ higher risk for tissue damage occurs in 
the area above the line
✔■■lower risk for tissue damage occurs in 
the area below the line
Higher mechanical loads reach the 
threshold for tissue damage earlier than  
lower mechanical loads
M
ec
ha
ni
ca
l l
oa
d/
tis
su
e 
di
st
or
tio
n
Time
✖
✔
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The amount of tissue deformation, i.e. the degree of change in tissue shape in response 
to the mechanical load, required to produce ischaemia is lower than that required for 
structural damage (Oomens et al, 2015). However, the threshold at which damage occurs 
from either mechanism will vary from patient to patient and will depend on numerous 
factors, e.g. the presence of comorbidities (such as cardiovascular disease and diabetes) 
that may reduce tissue perfusion and the condition and thickness of the tissue layers 
between the skin and bony prominence (Oomens et al, 2015). A combination of reduced 
tissue perfusion and less tissue between the skin and bony prominence may result in DTI 
particularly quickly.
OTHER EFFECTS INVOLVED
Two other mechanisms to consider in the aetiology of DTIs and PUs are:
■n Lymphatic occlusion – In addition to occluding blood vessels, mechanical loads can occlude 
lymphatic vessels and may cause the accumulation of metabolic waste products that 
contribute to tissue damage (Miller & Seale, 1981; Peart, 2016).
■n Ischaemia-reperfusion injury – Although counterintuitive, restoration of blood flow to 
an ischaemic tissue can exacerbate ischaemia-induced damage. Reperfusion initiates an 
inflammatory response that stimulates the formation of oxygen-derived free radicals and  
other agents that can cause further tissue damage (Collard & Gelman, 2001). An animal 
study of DTI found that reperfusion reversed tissue damage after a limited time of ischaemia, 
but that if ischaemia was prolonged, reperfusion exacerbated the existing tissue damage 
(Loerakker et al, 2011). Patients who experience hypotension, whether as a consequence 
of disease or as a result of other treatments, may be particularly prone to the effects of 
ischaemia-reperfusion injury.
Figure 5: Main mechanisms of 
tissue damage and cell death 
due to mechanical loading in 
the development of DTIs and 
PUs (adapted from Oomens 
et al, 2015) 
Deformation of tissue cells
Tissue damage and cell death
Within a few minutes After a few hours
Occlusion of blood and lymph vessels
Mechanical load
Structural damage to cells 
■n Cell membrane damage
■n Disruption of internal cell 
structure and function
■n Occurs at higher  
mechanical loads than 
ischaemia  
■n Causes cell death much 
more quickly than 
ischaemia
Ischaemia
■n Shortage of oxygen  
and nutrients
■n Accumulation of waste 
■n Occurs at lower mechanical loads than 
structural cell damage 
■n Causes cell death more slowly than 
deformation
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DIFFERENCES IN THE DEVELOPMENT OF DTIs AND PUs
The differences in clinical progression of DTIs and PUs suggest that although the underlying 
causes are similar, the initial site of damage is different. In DTIs, mechanical loading in the form 
of externally applied pressure causes tissue damage that occurs initially adjacent to the bony 
prominence and in the muscle layer if present (Figure 6). The damage then moves towards the 
surface in a manner sometimes described as ‘bottom up’ or ‘inside out’.
Conversely, in PUs, the mechanical load comprises pressure with superficial shear. These loads 
cause tissue damage initially at the surface; the damage works downwards, or ‘top down’ or 
‘outside in’ (Fife, date unknown; WUWHS, 2016).
In another analogy, DTIs have been likened to geological sinkholes. This analogy is also useful 
because it is in keeping with the frequent finding in DTIs of undermining due to tissue damage 
that is more extensive than initially apparent from the skin surface. In a similar analogy, PUs have 
been likened to potholes in a road (WUWHS, 2016).
Although a clear distinction has been made here to aid understanding of the differences in the 
development of DTIs and PUs, in clinical practice it is possible that the mechanisms sometimes 
occur together in the development of an area of pressure-induced damage. For example, 
a patient who has been immobile may start to develop a DTI, but then may regain some 
movement that introduces superficial shear which also contributes to the tissue damage.
The facts that DTIs can occur very quickly and start below the skin surface (often in muscle) 
suggest that high mechanical loads may be involved and that structural damage to cells is a 
major cause of tissue necrosis. These facts reinforce the need for timely risk assessment and 
frequent skin inspection
Figure 6: Differences in the 
sites of development of 
DTIs and PUs (adapted from 
WUWHS, 2016)
This diagram illustrates 
the different sites of 
development of DTIs 
and PUs, and the relative 
importance of types of 
mechanical loading in the 
development of each. 
•
Pressure Pressure
Superficial shear
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Subcutaneous fat
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An individual’s risk of developing a DTI or a PU is dependent on a complicated interplay of 
numerous factors (Coleman et al, 2013). At a basic level, the risk is related to the intrinsic ability 
of the patient’s tissues to withstand the effects of extrinsic risk factors such as externally applied 
mechanical loads, i.e. to a level of tissue tolerance. When the effects of the extrinsic risk factors 
exceed the specific tissue tolerance, the individual is at an increased risk of developing a DTI or 
PU (WUWHS, 2016). Tolerance to extrinsic risk factors will be reduced by a range of intrinsic 
risk factors (Box 5, page 10) such as immobility, reduced tissue perfusion and reduced sensation.
FACTORS THAT INCREASE THE RISK OF DTI
PUs and DTIs share many risk factors, but there are some risk factors that particularly increase 
the risk of a DTI. These can be divided into factors that restrict immobility or cause immobility, 
impair sensation, and reduce tissue tolerance (Figure 7, below; and Table 1, page 10).
In some conditions, several of these factors may be present and contribute to increased risk 
of DTI. For example, individuals with spinal cord injury can have reduced mobility, impaired 
sensation, hypotension and muscle atrophy (wasting) and so are at an increased risk of DTI 
(Gefen, 2014). A recent analysis of factors contributing to DTI in intensive care unit patients 
reported that the odds of developing a DTI increased by 20% for every hour increase in length of 
surgery (Kirkland-Kyhn et al, 2017).
Patients in intensive care units (ICUs), undergoing surgery, receiving acute care in hospital or 
in long-term care are at increased risk of DTI (Fleck, 2007)
Patients undergoing transitions in care, e.g. when being transferred from one facility to 
another (Preston et al, 2017), can be at an increased risk of DTI, particularly if not placed on an 
appropriate support surface during transfer or in the receiving clinical area
Patients undergoing other transitions, e.g. from being bed-bound to sitting in a chair, are also 
at an increased risk of DTI because the change in position will change the ways and the time 
period that mechanical loads are applied to the tissues and because the support surface may 
not be appropriate
Patients that have had a DTI may be at increased risk of the development of further DTIs or PUs 
because during the healing process the tissues are likely to have been remodelled, e.g. with scar 
tissue, and to have altered physical characteristics.
Who is at risk of DTI?
•
•
•
Figure 7: Categories of 
factors that increase risk 
of DTI
DTI
Restricted 
mobility/ 
immobility
Reduced tissue 
tolerance
Impaired 
sensation
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Major intrinsic risk factors
■n Immobility/reduced activity/altered posture – e.g. bed-fast, chair-fast, contractures
■n Reduced tissue perfusion – e.g. due to peripheral vascular disease, cardiopulmonary disease, 
diabetes, smoking, critical illness
■n Previous or existing PU 
Other important intrinsic risk factors
■n Reduced sensation –  e.g. spinal cord injury, stroke, local or general anaesthesia
■n Increased skin moisture – e.g. incontinence, perspiration
■n Increased age
■n Anaemia
■n Poor nutrition, including low blood albumin levels
■n Reduced general health status – e.g. acute illness, renal impairment, carcinoma
Box 5. Main intrinsic risk factors for PU and DTI (AWMA, 2012; Coleman et al, 2013; 
Coleman et al, 2014)
Table 1. Examples of PU risk factors particularly relevant to risk of DTI  (Berlowitz & Brienza, 2007; 
Black et al, 2016; Lustig et al, 2017; Preston et al, 2017; Kirkland-Kyhn et al, 2017)
Limited mobility or immobility Impaired sensation Reduced tissue tolerance
Effect of risk 
factor
■n The patient has reduced ability 
to change position independently 
and relieve pressure
■n The patient has 
reduced ability 
to detect signals 
from body tissues 
indicating that a 
change in position 
is required to 
relieve pressure
■n The threshold for tissue 
damage induced by 
mechanical loading is 
reduced
Examples of 
risk factors
■n Neurological disease, e.g. stroke, spinal cord injury
■n Sedation
■n Anaesthesia, e.g. local, epidural, spinal or general
■n Unconsciousness
■n Atrophy, fragility and/
or breakdown of soft 
tissues, e.g. muscle 
atrophy through acute 
or chronic illness or 
paralysis
■n Episodes of shock/
hypotension/poor tissue 
perfusion, e.g. due to 
vasopressors, cardiac 
arrest
■n Recent weight loss
■n Malnutrition
■n Dehydration
■n Change in skeletal 
architecture, e.g. 
amputation, contractures, 
diabetic foot changes
■n Previous PU or DTI
■n Prolonged sitting, e.g. in a chair, 
wheelchair, hard surfaces, such 
as toilet seats or washroom 
stools
■n In pain, e.g. from chronic 
disease, recent surgery
■n Prolonged confinement to a hard 
surface, e.g. the floor (after a 
fall or loss of consciousness), an 
emergency department trolley, 
radiology department surfaces, 
spinal board, operating theatre 
table or during transfer between 
healthcare facilities
■n Prolonged contact with and 
usage of medical devices
■n Neuropathy, e.g. 
due to diabetes, 
alcoholism, 
autoimmune 
disease, Guillain-
Barré syndrome/
chronic 
inflammatory 
demyelinating 
polyneuropathy, 
malnutrition
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Diagnosis of DTI
Several conditions other than DTI can present with discoloured, purple or maroon skin, skin loss over 
a darkened wound bed, or rapidly developing eschar (Black et al, 2016). Healthcare professionals and 
carers need to be aware of the characteristics of DTI and how to differentiate it from other conditions that 
may present in a similar way (Table 2 below, and Appendix 1, page 30). Taking a detailed history from the 
patient and careful assessment will be key to establishing the correct diagnosis.
If there is uncertainty over the diagnosis of a lesion that may be a DTI, the affected area should be 
treated as if it is a DTI (see pages 21-26) while the concern is escalated or a referral is made to the 
relevant service. The urgency of the referral should be appropriate to the possible diagnosis, e.g. 
necrotising fasciitis is life-threatening and requires emergency referral
Table 2. Distinguishing DTI from other conditions that present with discoloured (purple or maroon) skin +/- broken skin  
(Nair et al, 2014; NPUAP/EPUAP/PPPIA, 2014; Pieper, 2016; Black et al, 2016; Ousey et al, 2017b)
Condition Characteristics
DTI  
(Figures 8a and 8b,  
page 12)
n History of application of pressure over affected area
n Preceding event may have been 24–72 hours before recognition
n Presents as a purple or maroon area of non-blanchable discoloured intact skin which may be surrounded by non-blanchable 
erythema (Box 3, page 4) +/- an overlying area of dry skin, a thin blister over a dark wound bed, a blood-filled blister, an area 
of broken skin with a purple, maroon, black or white wound bed, or an area of thin dark eschar (see pages 3-4)
n Affected area may be painful, and firmer/softer, or warmer/cooler than the surrounding areas 
n Usually has a clearly defined edge
n Most commonly affects the heels, sacrum and buttocks; may occur under a medical device
Category 1 PU 
(Figure 8c, page 12)
n History of application of pressure over affected area 
n Skin of the affected area is intact with non-blanchable reddening (erythema) or discolouration in darkly pigmented skin, 
and is usually over a bony prominence
n Affected area may be painful, and firmer/softer, or warmer/cooler than the surrounding areas
Category 2 PU 
(Figure 8d, page 12)
n History of application of pressure over affected area 
n Presents as a shallow shiny or dry open ulcer due to partial thickness loss of the dermis without slough or bruising, and 
is usually over a bony prominence
n May also present as an intact or open/ruptured serum-filled blister
Bruise 
(Figure 8e, page 12)
n History of blunt-force trauma is common
n Due to extravasation of blood into tissues
n Usually takes about two weeks to heal
Haematoma n History of trauma is common
n Due to extravasation of blood; may produce a deep-seated palpable nodule
n Morel-Lavallée lesions are a type of haematoma that are due to trauma that separates the subcutaneous tissues from 
the underlying fascia and muscle; skin necrosis and infection may occur
Blood blister n History of trauma is common, e.g. pinching of tissue between two hard surfaces
n Forms a raised blister that is filled with blood; may be red initially and then become purplish or black
Skin tear 
(Figure 8f, page 12)
n History of trauma is common
n Common on the extremities of older people
n May cause full- or partial-thickness skin loss
n Often accompanied by bleeding 
Incontinence-associated 
dermatitis 
(Figure 8g, page 12)
n Usually associated with faecal and/or urinary incontinence
n Affects perineum, peri-genital area, buttocks, gluteal fold, upper thighs and lower back
n Affected area often has poorly defined edges
n Erythema is blanchable and may be blotchy, and may be accompanied by partial thickness skin loss and vesicles
Venous engorgement 
(Figure 8h, page 12)
n Can occur in dependent tissues in patients with poor cardiac output; may be associated with swelling due to oedema
n The colour of the affected area can change if moved, e.g. during elevation or position change; discolouration is blanchable
Arterial insufficiency n Skin may be pale or mottled red to bluish/purple colour, dry and hairless
n Often bilateral; patient may keep the limb(s) in a dependent position and complain of numbness, burning sensation and pain
n Slow capillary refill and pallor on elevation (Box 6, page 13); pulses in an affected limb may not be palpable
n Embolic events: small blood clots may cause sudden onset of ischaemia with pain and discolouration of the affected 
tissues, e.g. in the toes
•
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Figure 8: DTI and other conditions that may have a similar presentation 
See Table 2, page 11, for more information. 
a) DTI on buttock c) Category 1 PU
e) Bruise
b) Sacral DTI
f) Skin teard) Category 2 PU with blistering
g) Incontinence-associated dermatitis h) Venous engorgement
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Overview of assessment, 
management and prevention
The principles underlying the assessment, management and prevention of DTIs are similar to 
those for the assessment, management and prevention of PUs (Preston et al, 2017).
The assessment, management and prevention of DTIs should be undertaken in the context of 
mental capacity and consent (Box 7) 
FORMAL CARER, INFORMAL CARER OR PATIENT
For patients in community settings, e.g. in their own homes or in nursing homes, signs and 
symptoms of DTI may first be recognised by him- or herself, or by a formal or informal carer. 
The patient or carer noticing such signs should contact a registered healthcare professional as 
soon as possible, and in the meantime should:
■n Protect the affected area: 
- Make sure the patient does not sit or lie on the affected area and that nothing presses on it
- Cover broken skin or blistering with an appropriate low-adherent dressing as per local 
dressing formulary, if available; if not available, leave the broken or blistered area exposed 
and avoid touching it
■n Prevent any additional areas of pressure-induced damage:
- Continue any other PU prevention measures
- Keep the patient clean and dry
■n Encourage healthy eating and fluid intake (Figure 9, page 14).
■n Elevation of a limb 
affected by arterial 
insufficiency may 
cause pallor
■n In the lower limb, 
Buerger’s test can be 
used in assessment 
for lower limb 
ischaemia (Insall 
et al, 1989). For 
example, in the 
lower limb, elevation 
of the leg to an angle 
of 45 degrees to the 
bed surface for one 
to two minutes when 
the patient is lying 
on his/her back will 
cause pallor of the 
skin; then when the 
patient sits with the 
leg lowered over the 
edge of the bed, the 
skin may become 
bluish and then 
reddened
■n If arterial 
insufficiency is 
suspected, consider 
determining 
ABPI (ankle–brachial 
pressure index) and/
or referral to a 
vascular service
Box 6. Clinical 
examination to 
test for arterial 
insufficiency
■n Valid consent is required before touching a patient, whether that is to assist with self-care tasks 
such as dressing, to examine skin as part of PU prevention, or to undertake invasive procedures
■n Valid consent requires that the patient has the mental capacity to give consent, i.e. that the patient 
can understand and use information to make a decision
■n The Mental Capacity Act 2005 covers adults aged over 16 years in England and Wales and sets out 
criteria for establishing mental capacity. The Act has five main principles:
- Assume the patient has mental capacity unless it is proven otherwise by undertaking a mental 
capacity assessment
- Ensure all practical steps have been taken to support the patient with the assessment before 
deciding they lack mental capacity
- An unwise decision does not mean that the patient lacks mental capacity
- Any decision made on behalf of a patient lacking mental capacity must be made in his/her  
best interests
- Always consider whether there is a least restrictive option when making any best-interests 
decision
■n A patient who has mental capacity should be provided with sufficient information in a way that they 
can understand to inform their decision about consent, such as the options available, the risks and 
benefits, and the implications of their choices
■n Any decision made in relation to a patient who lacks capacity should be made in that person’s  
best interests
■n The issues of capacity and consent are covered in Scotland by the Incapacity (Scotland) Act (2000) 
(Scottish Government, 2000) and in Northern Ireland by the Mental Capacity Act (Northern 
Ireland) 2016 (TSO, 2016)
■n Healthcare professionals and carers should follow the consent policies and procedures of  
their organisation
Box 7. Mental capacity and consent (Department of Health, 2009; Mughal, 2014; 
Nichols, 2014)
•
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REGISTERED HEALTHCARE PROFESSIONAL/ALLIED HEALTHCARE PROFESSIONAL
The diagnosis of a DTI may be clear on presentation, but referral as appropriate, e.g. to a tissue 
viability service, may be needed if it is not (Table 2, page 11). Experienced healthcare professionals 
aware of the evolution of DTIs may decide to delay referral for a short period (e.g. up to 1–2 weeks) 
if the area appears stable, and the patient has no other symptoms of illness that warrant onward 
referral. In such cases, assessment and management should be commenced as if for a DTI alongside 
frequent monitoring to see whether the diagnosis becomes more evident (Figure 10, page 15).
It is important that an area showing signs and symptoms of a DTI is immediately protected 
from any further mechanical load even when the diagnosis is not clear; do not wait for a 
referral to be completed or for confirmation of the diagnosis•
Prevention of DTI should generally adopt the same principles as the management of DTI.  
A focus of management of DTI is the prevention of further tissue damage (Preston et al, 2017). 
Information on the:
■n Assessment of a patient with signs and symptoms of a DTI is on pages 16-20
■n Management of a patient with signs and symptoms of a DTI is on pages 21-26
■n Prevention of DTI is on pages 27-28.
Figure 9: Overview 
of assessment and 
management of a patient 
with signs and symptoms of 
a DTI by the patient, family 
member or formal/informal 
carers, and registered 
healthcare professionals 
Signs and symptoms of a DTI
■n Reported by the patient 
■n Detected on regular skin inspection or during routine care
Recognised initially by:
Formal carer, informal carer, family member  
or patient
■n Refer immediately to a registered 
healthcare professional
AND without waiting for the patient to be 
seen, and after establishing capacity and 
consent (Box 7, page 13):
■n Make sure the patient does not sit or 
lie on the affected area, that nothing 
presses on it and that it is not in contact 
with a bed, chair, seat, device or  
the floor
■n Cover broken skin or blistering with a 
low-adherent dressing if available
■n Provide pain relief as prescribed/
according to local policy
■n Keep the patient clean and dry
■n Continue using any other PU prevention 
measures or equipment
■n Encourage healthy eating and  
fluid intake
Registered healthcare professional/allied 
healthcare professional
■n Diagnose DTI 
OR
■n If the diagnosis is unclear (see Table 2, 
page 11), refer according to local policy for 
clarification, or if sufficiently experienced 
and the patient has no other symptoms 
that require referral, consider delaying 
referral for a short period of observation
AND without delay, and after establishing 
capacity and consent (Box 7, page 13), and 
in the context of a multidisciplinary team:
■n Proceed with holistic assessment (pages 
16-20) and management (pages 21-26)
■n Figure 10, page 15
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Figure 10: Principles of 
assessment, management 
and prevention of DTI
Assess
■n General health
■n Nutrition and hydration
■n Skin
■n Pain
■n Level of mobility and activity
■n Continence status
■n Risk for developing further DTI/PU
■n Availability and use of offloading/
pressure redistribution equipment
■n Psychosocial status
■n Insight and understanding of  
DTI/PUs
■n Patient/family/carer objectives
■n DTI (wound)
Define objectives of management, e.g.:*
■n Reduce risk of further tissue damage (further DTI/PU)
■n Healing of DTI
■n Reduction in pain
Reduce risk of further tissue damage (involving the multidisciplinary 
team as appropriate):*
■n Offloading/regular repositioning/pressure redistribution
■n Optimise patient condition – manage comorbidities and incontinence; 
improve nutrition and hydration; protect skin; optimise mobility
■n Manage pain, e.g. pain associated with repositioning
Manage the DTI:*
■n Offload the DTI
■n DTI wound management
■n Manage pain associated with the DTI
Record and report DTI according to local policy for incident reporting 
Patient, family and carer education
Monitor and reassess regularly
■n Assess DTI healing progress at least weekly; inspect skin at least daily
■n Conduct ongoing PU risk assessment
■n Effectiveness and suitability of offloading/pressure redistribution/
repositioning regimen
■n Consider the patient’s other needs/management objectives for  
other conditions
Refer according to local policy:
■n For clarification of diagnosis if necessary
■n If condition of the DTI is deteriorating rapidly
■n If condition of the DTI is not improving within 2 weeks (or sooner if the 
patient is not stable)
Patient with signs and symptoms of a DTI 
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*Taking into account all 
of the patient’s needs
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Assessment of DTI
A patient with a DTI should undergo a structured holistic assessment that includes:
■n The patient’s overall health, including comorbidities, nutrition and skin condition
■n The DTI
■n Identification of the risk factors for DTI and PUs (Figure 10, page 15). 
A holistic and structured assessment of a patient with a DTI will provide essential information 
for devising and implementing an appropriate management plan. The results of the holistic 
assessment must be documented according to local policy (Chamanga & Ward, 2015)
GENERAL HEALTH STATUS
Assessment of general health should include:
■n Medical and surgical history – may reveal risk factors for the development of pressure-induced 
damage, e.g. stroke, diabetes
■n History of previous PU or DTI – may indicate increased risk
■n Current health – active comorbidities; new symptoms that may need investigation
■n Medication – e.g. medication that causes sedation may increase risk of DTI, or chronic use of 
steroids may impair wound healing
■n Factors that may adversely affect healing (Box 8, page 17). 
Ascertainment of general health status will allow proposed management (and prevention) of the 
DTI to be placed in context. In some situations, e.g. in critical illness or end of life care, the other 
needs of the patient may take priority over DTI prevention and management. Where this is the 
case, such decisions should be clearly documented
NUTRITION
Poor nutritional status and inadequate dietary intake are risk factors for PU development and impaired wound 
healing (NICE, 2014; Posthauer et al, 2015). Patients should be assessed for recent weight loss and problems 
associated with eating and drinking. The Malnutrition Universal Screening Tool (MUST) is an example of a 
screening tool cited by the National Institute for Health and Care Excellence (NICE, 2006; Elia, 2003).
Patients suspected of having poor nutrition should undergo nutritional assessment according to 
local policy, which may include referral to a dietician. Patients with difficulty eating or drinking 
may also benefit from assessment by an occupational therapist
SKIN ASSESSMENT
Skin assessment should ensure examination of the patient’s entire skin for signs of pressure-induced 
damage, e.g. areas of non-blanchable erythema (Box 3, page 4), including under medical devices, such as 
face masks, and for general condition. Dry skin, particularly at the heels, is a risk factor for pressure-related 
damage (Lechner et al, 2017).
Checking for evidence of pressure-induced damage should involve inspecting and palpating the skin, 
and asking the patient about any areas of discomfort or pain: ‘look, feel, ask’
Careful attention should be paid to inspection of areas in which the patient is complaining of pain. If the 
area cannot be accessed easily for inspection, e.g. because of difficulties with or uncertainty over the 
removal of a device or bandage, the concern should be escalated as soon as possible. After removal of the 
device and skin inspection, careful consideration may be required of the suitability of reapplication of the 
device and whether there is need for an alternative.
•
•
•
•
RECOGNISING, MANAGING AND PREVENTING DEEP TISSUE INJURY (DTI) | 17
•
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■n Verbal pain rating scale – the patient indicates from a list of phrases ranging from ‘no pain’ to ‘severe 
pain’ which phrase describes their pain best
■n Numerical pain rating scale – the patient is asked to score their pain on a 0 to 10 scale, where 0 = no 
pain and 10 = the worst pain imaginable
■n Visual analogue scale – the patient is presented with a line, one end of which represents no pain and 
the other end the worst pain imaginable, and is asked to draw a mark on the line to represent the 
level of pain 
■n Extremes of age
■n Diabetes
■n Peripheral arterial 
disease
■n Severe liver or 
kidney disease 
■n Obesity
■n Immunosuppres-
sion – e.g. radiation 
therapy, AIDS
■n Medication – e.g. 
steroids, immu-
nosuppressants, 
chemotherapy, 
non-steroidal 
anti-inflammatory 
drugs (NSAIDs)
■n Smoking
■n Alcoholism
■n Stress
■n Malnutrition
Box 8. General factors 
that may impair 
wound healing (Guo 
& DiPietro, 2010; 
Anderson & Hamm, 
2012)
Box 9. Examples of scales for assessment of pain severity (Solowiej & Upton, 2010)
Heels are the most common site of DTI, but may be difficult to access. Particular effort may be needed 
to ensure that any foot coverings (e.g. slippers, shoes, socks, tights, anti-embolic stockings) are 
removed regularly, e.g. at least daily or more frequently in patients at high risk, to allow examination.
Patients who are incontinent or who had been confined to the floor after falling may have signs of 
incontinence-associated dermatitis (Table 2, page 11).
All of the patient’s skin should be examined: patients may have more than one DTI (Figure 11), 
also have a PU or a skin condition that increases risk of further pressure-induced damage
Skin assessment provides an opportunity to talk to the patient about risk for DTIs and to provide 
advice on avoidance of pressure-induced damage and the signs and symptoms if it does occur. 
PAIN ASSESSMENT
Assessment of pain is important because:
■n DTIs can cause pain
■n Pain may occur before physical signs of pressure-related damage occur
■n In a DTI with an open wound, a sudden onset or an increase in pain may indicate infection
■n Pain and psychological stress can adversely affect wound healing
■n Pain occurring during movement may reduce mobility, compounding risk for further pressure-
induced damage (Gorecki et al, 2009; Woo, 2012; Black et al, 2016).
Repeated use of the same method of assessment will assist in monitoring pain and the effectiveness of 
pain-relieving interventions. The method of pain assessment should be selected according to the patient’s 
cognitive and linguistic abilities. In patients with reduced cognitive ability, non-verbal cues, body language 
and the family/carers’ knowledge of the patient may aid assessment of pain (RNAO, 2016).
Patients should be assessed for DTI-related pain and non-DTI-related pain. Assessment 
should include evaluating the location, nature, frequency, timing, and severity of pain (Box 9) 
and factors that initiate or relieve pain
Figure 11: Multiple areas of DTI and 
pressure-induced damage
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LEVEL OF MOBILITY AND ACTIVITY
A central principle of the management (and prevention) of DTI is removal of any mechanical load 
from the affected area and any other areas at risk of pressure-induced damage. A patient who 
is able to perform purposeful movements, i.e. is able to lift or tilt a body part completely away 
from the surface they are resting on, can be encouraged to change position regularly as part of a 
pressure-relieving regimen.
RISK FOR FURTHER PRESSURE-INDUCED DAMAGE (DTI OR PU)
A patient with a DTI is at risk of developing a further DTI or a PU. An understanding of the risk 
factors for DTI and PUs (Box 5 and Table 1, page 10) will enable healthcare professionals, carers, 
patients and family members to quickly identify which risk factors are relevant to the patient. 
This should include understanding that development of an acute illness in a patient already at 
risk of pressure-related damage will further increase risk. Consideration should also be given 
to all aspects of care that may be associated with risk, e.g. prolonged sitting without position 
change in a chair or on a toilet (Lustig et al, 2017).
The patient’s level of mobility, along with identification of DTI or PU risk factors and aspects of care that 
may be associated with risk for pressure-induced damage can be used to inform the management plan
PU risk assessment tools for different patient groups are available and should be used according 
to local policy (Table 3). Currently, there is no risk assessment tool specific to DTIs.
SUPPORT SURFACES AND PRESSURE REDISTRIBUTION EQUIPMENT
All support surfaces and pressure redistribution equipment in use by the patient, including 
its physical condition, suitability and whether use is appropriate and safe, should be assessed 
(RNAO, 2016). Examples of equipment to consider include bed, chair/wheelchair, toilet seat, 
bathing stool, foot rest, transfer equipment, and interventional medical device.
OTHER
■n Psychosocial status – including for patients in the community, the formal and informal care 
systems that may be in place.
■n Understanding of DTI and PUs – ascertaining the level of insight into DTI and PUs of the 
patient, family, and, where appropriate, the carer may reveal the need for education to aid 
understanding of management strategies and involvement in care planning.
•
Table 3. PU risk assessment tools (Wounds UK, 2013a; Fletcher, 2017)
Patient 
population
Appropriate risk assessment tool
Adults ■n Acute care: Waterlow Score (Waterlow, 2005); PURPOSE T (Coleman et al, 2017)
■n Critical care: Jackson/Cubbin Pressure Area Risk Calculator (Jackson, 1999)
■n Community care: Walsall Community Pressure Sore Risk Calculator (Chaloner & Franks, 
2000)
■n Orthopaedic: Pressure Sore Prevention Score (Lowthian, 1989)
Older people ■n Norton Pressure Ulcer Risk-Assessment Scale (Norton, 1989)
■n Braden Scale for Predicting Pressure Sore Risk (Bergstrom & Braden, 1992)
Paediatric 
patients
■n Glamorgan Paediatric Pressure Ulcer Risk Assessment Scale (Willock et al, 2009)
■n Braden Q Scale (Curley et al, 2003)
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DTI ASSESSMENT
Assessment of a DTI will provide a baseline from which to monitor progress or detect 
deterioration. The assessment should be clearly documented according to local policy. Serial 
photographs may be helpful and should be obtained after gaining patient consent and stored 
according to local policy (Farid et al, 2014; Sperring & Baker, 2014).
The assessment should include, as a minimum, the location of the DTI and measurement of the 
size of the affected area and blistering or open wound if present. Systematic assessment of the 
DTI will be aided by using a wound assessment framework (Box 10), even when the skin over the 
DTI remains intact.
If the skin is broken, the wound bed should be assessed for the proportions of granulation tissue, 
necrotic tissue/eschar, slough and epithelial tissue present (Ousey & Cook, 2012). Exudate 
levels, though difficult to assess, influence dressing selection. Exudate consistency, colour and 
smell may also indicate infection (Wounds UK, 2013b). See Box 11 for a summary of signs of 
possible local wound infection. If bone can be probed in the base of the wound or is exposed, 
osteomyelitis should be suspected (Rennert et al, 2009). Systemic signs of wound infection 
include malaise and pyrexia.
In patients with more than one DTI, or a DTI and another wound or area of skin damage such 
as incontinence-associated dermatitis, each area of damage or wound should be individually 
assessed and categorised to facilitate appropriate care planning and management
■n TIME(S) (Schultz et al, 2004; Wounds UK, 2016)
- Tissue
- Infection/inflammation
- Moisture imbalance
- Edge of the wound
- (Surrounding skin)
■n Triangle of Wound Assessment (Dowsett et al, 2015)
- Wound bed
- Wound edge
- Periwound skin
■n New, increased, or altered pain
■n Malodour or change in odour
■n Increased or altered/purulent exudate
■n Delayed healing
■n Periwound oedema
■n Bleeding or easily damaged granulation tissue
■n Altered wound bed colour
■n Induration of periwound skin
■n Pocketing and bridging
Box 10. Frameworks to aid systematic wound assessment
Box 11. Signs and symptoms of possible wound infection in a DTI with broken skin or an open 
wound (WUWHS, 2008)
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The Expert Working Group recommends that a DTI remains recorded as a DTI, and  
is not recategorised at any point (e.g. to a Category 3 or 4 PU), even if it evolves
The Expert Working Group recommends that the notes of a patient with a DTI are  
flagged to alert all healthcare professionals because of the likely increase in risk for  
further pressure-induced damage
DIAGNOSTIC TESTS FOR DTI
The difficulties of identifying the early stages of DTI have generated interest in the potential 
of tests that may indicate the presence of tissue damage. Tests under investigation for the 
detection of pressure-induced damage include assessing biomarkers in plasma, sweat and urine 
related to muscle damage and changes in concentrations of inflammatory mediators (Ferguson-
Pell & Hagisawa, 1988; Knight et al, 2001; Loerakker et al, 2012; de Wert et al, 2015; Krishnan et 
al, 2016; Worsley et al, 2016).
Ultrasound scanning (USS) can detect subcutaneous tissue changes in DTI prior to changes 
becoming visible on the skin surface (Scheiner et al, 2017). Therefore, USS has potential as a 
screening tool in patients considered to be at risk. However, the clinical utility of USS for this 
indication is likely to be limited because of the resource, training, time and cost implications of 
widening access to USS.
In areas of pressure-induced damage, the amount of interstitial fluid increases in response to the 
inflammatory process. As a result, hand-held devices to measure subepidermal moisture (SEM) 
have been developed to aid early identification of PUs (Moore et al, 2016). Clinical studies have 
reported that SEM values increase with increasing tissue damage (Oliveira et al, 2017).
Thermography has been investigated to assess its ability to predict progression of discoloured 
intact skin to necrosis (Cox et al, 2016). The study found that intact discoloured areas with 
cooler skin temperatures in the centre in comparison with surrounding skin were significantly 
more likely to develop necrosis by day 7 than if the skin was warmer than the surrounding areas. 
However, nurses participating in the study were unsure of the feasibility of using thermography in 
clinical practice and more investigation is required.
Currently, there is no widely accessible and reliable test to aid diagnosis of DTI
A DTI may be subject to reporting and investigation according to local policy
•
•
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Management of DTI
The management and prevention of a DTI share many similarities. In fact, prevention strategies 
are used in DTI management to aid healing and prevent deterioration of the DTI and to prevent 
any further pressure-induced damage (Figure 12). Management of DTI therefore comprises local 
treatment of the DTI plus DTI prevention. Prevention of DTI is discussed on pages 27-28.
The assessment of the patient with a DTI will indicate appropriate objectives that will form the 
basis of the management plan. The plan needs to take into consideration all the patient’s needs. 
In some cases, the DTI aspects of the plan may need to be adjusted or take lower priority. 
The objectives and plan should be discussed and agreed where possible with the patient, family 
and carers. Management of DTI is likely to require a multidisciplinary team approach, which may 
also include as appropriate nurses, tissue viability nurses, healthcare assistants, physiotherapists, 
occupational therapists, podiatrists, dieticians, medical specialists, surgeons, bioengineers and 
social workers (RNAO, 2016).
Patients with a DTI often have other conditions. In some situations, e.g. in patients who are 
haemodynamically unstable, the management of these conditions needs to take priority over, 
or may complicate, the management (and prevention) of DTIs or PUs. In such cases, this may 
mean that it is necessary to recognise that the DTI is likely to evolve and deteriorate
OPTIMISE PATIENT CONDITION AND NUTRITION
Optimising the patient’s condition aims to remove or ameliorate any modifiable risk factors for 
pressure-induced damage, e.g. comorbidities or incontinence, and any factors that may impede 
healing identified during assessment.
Patients should be encouraged to eat healthily and to maintain good levels of hydration. If a 
patient is unable to achieve an adequate nutritional intake with meals, fortified foods and/or 
high protein oral nutritional supplements or enteral/parenteral nutritional support as appropriate 
should be considered (NPUAP/EPUAP/PPPIA, 2014).
OFFLOADING, PRESSURE REDISTRIBUTION AND REPOSITIONING
As mechanical loading, mainly in the form of pressure, is the main cause of DTI, it is logical to 
remove pressure from the affected area and, as far as possible, reduce the intensity and duration 
of pressure over other areas that may be at risk of pressure-induced damage.
Wherever possible, it is important to offload a DTI and avoid exposing it to any form of 
mechanical load
In an at-risk patient who reports pain in an area in which a DTI may occur, but who has no other 
signs of DTI, the affected area should be offloaded if possible and monitored very frequently
A reduction in mechanical load can be:
■n Partial – i.e. produce a reduction in mechanical load, known as pressure redistribution; this 
may be intermittent or continuous
■n Complete – i.e. totally remove mechanical load, known as offloading; this may be intermittent 
or continuous.  
In practice, regular repositioning, which is used to offload areas, and equipment, which may 
redistribute pressure or offload, are often used in combination. Table 4, page 22, provides 
information on offloading according to the most common locations of DTI.
•
•
•
Management of DTI:
■n Treatment of the 
local area of tissue 
damage
PLUS
Prevention of DTI:
n■ Measures to 
prevent further 
pressure-induced 
damage
Figure 12: Management of 
DTI includes prevention
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Table 4. Offloading for a DTI according to location (Levy et al, 2015; WUWHS, 2016; Stephens & Bartley, 2017)
Location of 
DTI
Tips on repositioning/offloading/pressure redistribution
Heel ■n Reposition the patient to offload pressure from the heels when sitting or lying by ensuring they are not in contact with 
the bed, floor, foot rest etc, i.e. the heels are ‘suspended’ or ‘floating’
■n Devices that can be used to aid heel offloading:
- Boot – air, gel, foam, fibre
- Heel zone mattress
- Pillow or cushion (Figures 13 and 14, pages 24 and 25)
- Silicone cup
- Trough
- Wedge
■n Rigid framed devices may be needed for ambulant patients
■n On intact skin, consider use of a dressing designed to reduce exposure of the DTI to mechanical loads* (see page 26 for 
the management of DTI with broken skin or an open wound)
Sacrum/ 
ischial 
tuberosity
■n Reposition the patient to offload the sacrum/ischial tuberosities when lying or ask the patient to reposition themselves 
if possible and safe to do so
■n In bed, use the 30-degree tilt side-lying position (Figure 14, page 25) and avoid the patient lying on their back (supine)
■n Minimise time seated; avoid sitting patients with an ischial DTI in a fully erect posture; patients should be encouraged to offload 
intermittently while sitting, e.g. by lifting themselves completely off the seat, sideways leans, forward tilts and leans, and standing
■n On intact skin, consider use of a dressing designed to reduce exposure of the DTI to mechanical loads* (see page 26 for 
the management of DTI with broken skin or an open wound)
Under a 
medical 
device
■n Where possible, change the location or shape of the medical device, e.g. for oxygen masks, use a different mask shape/
size and/or alternate mask use with nasal cannulae
■n Regularly lift and reposition the device (at least as frequently as general repositioning), ensuring that the tension of any 
holding straps or fixation is sufficient for function of the device but is not higher than necessary
■n The use, positioning and repositioning of medical devices in patients who are oedematous requires careful consideration
■n On intact skin, consider use of a dressing (see page 26 for the management of DTI with broken skin or an open wound); 
care should be taken not to select a dressing that does not interfere with the function of the device and that does not 
increase pressure, e.g. is not too thick
*Dressings with low friction outer surfaces may reduce superficial mechanical loads. Dressings with multiple layers have been found in 
computer models of the heel to dissipate mechanical loads at the bone:tissue interface more effectively than single-layer dressings; this effect 
may be due in part at least to the horizontal displacement of the different dressing layers relative to each other and to a cushioning effect.
Even when equipment for offloading and pressure redistribution is in use, the patient should be 
repositioned regularly, unless contraindicated, and should undergo regular reassessments and 
skin inspections (NPUAP/EPUAP/PPPIA, 2014)
Patient preference, comfort and concordance should be taken into account when offloading 
and repositioning
Repositioning
Frequent repositioning is an important method of intermittently offloading the tissues. 
Positioning can also be used to avoid applying pressure to an existing DTI. The exact nature of 
the repositioning regimen will depend on the:
■n Patient’s level of mobility and whether, and to what extent, they can reposition themselves
■n Patient’s ability to tolerate the new position
■n Location of existing pressure-induced damage – e.g. while in bed a patient with a sacral DTI 
might be positioned on their left and right sides only and not on the back
■n Location of the patient – e.g. in bed or a chair
■n Support surface in use (NPUAP/EPUAP/PPPIA, 2014).
•
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A repositioning regimen should describe the positions to be used along with the frequency and 
duration of the position change, and should be reviewed regularly (Box 12) (NPUAP/EPUAP/
PPPIA, 2014). The frequency of repositioning will depend on patient risk. Those who are at higher 
risk and are more susceptible to pressure-induced damage need to be repositioned  
more frequently. 
As a guide, patients should be repositioned every 2–4 hours when lying on a pressure 
redistributing mattress and should shift their weight every 15 minutes if sitting (NPUAP/EPUAP/
PPPIA, 2014; RNAO, 2016). Any aids used to assist with repositioning (e.g. hoists, glide sheets) 
should prevent further tissue trauma and use should be documented. After repositioning, sheets, 
garments and incontinence products should be wrinkle-free. In general, the number of layers 
between a patient’s skin and a therapy surface should be kept to a minimum.
Devices including pillows, wedges, gel or fluidised mouldable positioners can be used to support a 
patient in a new position (Preston et al, 2017; NPUAP/EPUAP/PPPIA, 2014). Beds that allow the 
angle of the head and knee/foot sections to be adjusted independently can aid patient positioning 
(Preston et al, 2017).
Offloading and repositioning do not necessarily require specialist equipment; pillows can be used to 
good effect to support a patient in a position or can be used to provide offloading, e.g. of the heels if 
placed under the lower legs, or of bony prominences if placed either side
After repositioning, always check that the area(s) of concern are properly offloaded
Independent movement by a patient can move a body part away from a preventative device, e.g. if 
the legs are moved from pillows used for heel offloading, the heels may come into contact with the 
support surface. Consider the use of an appropriate alternative, e.g. a patient-worn removable or 
non-removable device or a mattress with inbuilt heel zone, if independent movement is problematic
•
•
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■n Avoid whenever possible positioning a patient directly on to a 
DTI (or a PU)
■n Where safe and possible encourage patients to reposition themselves 
by lifting vulnerable tissue areas clear of the support surface
■n When assisting or moving a patient to a new position:
- Follow local manual handling procedures and policies
- Avoid ‘dragging’ the patient along the support surface as this 
creates external shear forces
■n Ensure manual handling equipment and medical devices are 
not left under the patient, unless designed to be left in place
■n Repositioning in a bed:
- Use the 30-degree tilted side-lying position (Figure 14, page 
25) and alternate moving from right side to back to left side 
as appropriate; if this cannot be tolerated use the prone 
position if not contraindicated
- Avoid 90-degree side-lying or semi-recumbent postures
- Limit head of bed elevation to 30 degrees or less, unless 
medically contraindicated or if higher elevation is required for 
feeding, digestive or respiratory considerations
- Pillows, wedges, and gel or fluidised positioners can aid positioning
- If necessary, a knee break (gatch) can be used to reduce the 
risk of the patient sliding down the bed
- For taller patients, consider use of bed extensions and foam squabs 
to avoid feet being wedged against the foot plate of the bed
- Reposition every 2–4 hours or more frequently if there are 
signs of deterioration 
■n Repositioning while seated (in a chair or wheelchair)
- Ensure the chair is suitable for the size and weight of the 
patient and fits correctly (Box 13, page 24)
- Select a seating position that:
• Is stable
• Is acceptable to the patient and allows them to carry out 
their full range of functions
• Ensures support for the feet (on the floor or appropriate footrest) 
and arms
■n Reassess the effectiveness of the repositioning regimen 
regularly with respect to enabling the DTI to heal and 
prevention of other areas of pressure-induced damage
Box 12. Repositioning a patient with a DTI (NPUAP/EPUAP/PPPIA, 2014; Moore & van Etten, 2014; Preston et al, 
2017; Stephens & Bartley, 2017)
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Figure 13: Heel DTI offloading 
using a pillow for a patient 
lying on their back in bed 
The pillow should be 
positioned under the full 
length of the calf with the 
knee slightly flexed. The pillow 
should not be in contact 
with the area of the Achilles 
tendon. Check the heel is not 
touching the bed by passing a 
hand underneath.
Pressure redistribution
Patients with a DTI, or at increased risk of a DTI or other pressure-induced damage, should be 
placed on a pressure redistribution support surface selected according to local policy. Pressure 
redistribution support surfaces distribute the mechanical load more uniformly and so reduce the 
load or pressure over bony prominences (International Review, 2010). Pressure redistribution 
support surfaces are available in a wide range of formats including mattresses, integrated bed 
systems, mattress overlays, seat cushions and toilet seats.
Support surface selection should consider the patient’s needs and should be appropriate for 
use in the care setting (NPUAP/EPUAP/PPPIA, 2014)
Pressure redistribution surfaces should be considered for the bed and seating (including chairs, 
wheelchairs, toilet seats and bathing/showering stools) (Table 5, page 25). Air-fluidised and 
alternating pressure surfaces can be useful for patients who are acutely ill and/or who cannot be 
repositioned (Ovens, 2012).
Support surfaces should not replace good care and repositioning, and their use should be 
reassessed regularly
As the patient improves, the support surfaces in use should continue to be reassessed carefully to 
ensure suitability and that the surface does not hamper independent movement.
PAIN MANAGEMENT
In addition to management of any background pain, pain management may need to be 
considered for repositioning and during dressing changes or debridement.
■n Seat height: The patient should be able to put their feet on the floor comfortably or, if in a wheelchair, 
on the footrests, with the ankle in a normal position
– If the seat is too high, the patient may slide forward and slump back to put their feet on the floor or 
footrest and increase loading over the sacrum
– If the seat is too low, additional pressure may be put over the ischial tuberosities
■n Seat depth: There should be a space equivalent to the width of two fingers or 2.5cm between the front 
of the seat and the back of the patient’s legs
– If the seat is too deep the patient may need to slide forward to be able to put their feet on the floor  
or footrest
– If the seat is too shallow, the front edge of the seat may dig in to the back of the patient’s legs and 
cause pressure-induced damage
■n Seat width: There should be a space of 2.5cm between the patient’s hips and the side of the chair/
wheelchair on each side
– If the seat is too wide, the patient may not able to maintain a good posture
– If the seat is too narrow, movement and transfers may be hampered and pressure-induced damage 
may occur on the hips and buttocks
■n Armrest height: Should support the elbows comfortably when seated
– Armrests that are too low may cause postural problems that result in pressure-induced damage in 
other body parts
– Armrests that are too high may cause elbow joint discomfort 
For more information on seating, see Stephens & Bartley (2017).
Box 13. Checking chair fit (Stockton et al, 2009; Stephens & Bartley, 2017)
•
•
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Figure 14: The 30-degree tilted 
side-lying position (Wilson, 
2008)
After positioning the patient 
so that they are at a 30-degree 
angle to the surface of the bed, 
check that the sacrum and 
heels are not in contact with 
the bed; patients with obesity 
may need to be turned to a 
higher angle (45 degrees) to 
offload the sacrum (Moore & 
van Etten, 2014).
SKIN INSPECTION AND MANAGEMENT
The patient’s skin should be inspected regularly (at least daily) for signs of pressure-induced 
damage including non-blanchable erythema and DTI (NPUAP/EPUAP/PPPIA, 2014). The skin 
under medical devices should be inspected at least twice daily for signs of pressure-induced 
damage (NPUAP/EPUAP/PPPIA, 2014).
Regular skin inspection is an essential part of DTI management and of pressure-induced 
damage prevention
The patient’s skin should be kept clean and dry. Cleansing should use a pH balanced skin cleanser. Dry skin 
can be moisturised with a non-sensitising, fragrance and alcohol-free moisturiser (Norton et al, 2017).
If the patient is incontinent, reversible causes such as urinary tract infection or constipation 
should be treated. The skin should be cleansed at least once daily or after each episode of faecal 
incontinence. A skin protectant/barrier should be applied to areas with or at risk of incontinence-
associated dermatitis (Beeckman et al, 2015; Fletcher, 2015).
LOCAL DTI MANAGEMENT
The approach to the local management of a DTI depends on whether the skin is intact.
DTI with unbroken skin
A DTI with unbroken skin can be left uncovered if acceptable to the patient, family and carers. If a 
dressing is applied, it should have a low friction outer surface. The skin under the dressing should 
be inspected at least once daily and the dressing changed in accordance with the manufacturer’s 
instructions (WUWHS, 2016). In general, blisters should be left intact. On occasion, a blister may 
be deroofed under aseptic conditions, e.g. if a heel blister is preventing mobilisation.
Table 5. Types of pressure redistributing support surfaces (Ovens, 2012; Fletcher et al, 2015)
Type of support 
surface
Description
Reactive support surfaces
Foam ■n Comprise a single type of foam or layers of foam of different densities
Air- or gel-filled ■n Comprise air- or gel-filled compartments or columns
Low air loss ■n Air is permitted to escape through small holes in an air-filled support 
surface; may aid control of skin temperature and moisture
Air-fluidised ■n Contains small particles, e.g. silica beads. When air is forced through the 
particles they take on the properties of a liquid (i.e. become fluidised). Air 
escapes through the cover
Active support surfaces
Alternating pressure ■n Sections of the support surface inflate and deflate cyclically to intermittently 
remove pressure
Hybrid support surfaces
Non-powered ■n Comprise air cells with a layer of foam or air cells that have a foam core
Powered ■n Comprise alternating pressure air cells with a layer of foam or alternating air 
cells that have a foam core
•
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30 degrees
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DTI with broken skin or an open wound
A DTI with broken skin or an open wound should be cleansed and covered with a dressing that 
is appropriate for exudate level, wound bed tissue type and condition of the periwound skin with 
the aim of promoting moist wound healing (NPUAP/EPUAP/PPPIA, 2014). The cleansing agent 
and dressing should be selected according to local policy. If exudate levels are high, negative 
pressure wound therapy may be appropriate (Wounds UK, 2013b).
In general, debridement of a DTI should be approached conservatively. Surgical debridement is 
reserved for severe cases. An antimicrobial dressing can be considered for an ‘open’ DTI that is at 
high risk of infection or that is showing clinical signs and symptoms of infection (Box 11, page 19) 
(NPUAP/EPUAP/PPPIA, 2014).
The choice of dressing applied to a DTI with broken skin or an open wound should be based 
on the needs of the wound as determined by structured wound assessment and should follow 
local dressing formulary guidance
Healing progress should be monitored at least weekly and documented. For a DTI with an open 
wound, a tool such as the Bates-Jensen Wound Assessment Tool (BJWAT), the Pressure Ulcer 
Scale for Healing (PUSH) or the Pressure Sore Status Tool (PSST) may aid monitoring of healing 
progress (NPUAP/EPUAP/PPPIA, 2014).
PATIENT, CARER AND FAMILY EDUCATION
Education should include what a DTI is, how it is caused, how to recognise it, what the treatment 
is, how it can be prevented and where to get help or further information. Management of 
expectations including time frames and likely outcomes, where possible, should also be included.
The content and mode of delivery should be tailored to the needs of the individual. A combination of 
educational methods may be helpful. A discussion allows the information presented to be tailored to 
the understanding of the individual and the opportunity to ask questions. 
Combining discussions with other methods of providing information, e.g. printed leaflets and 
website links, will give further opportunities for learning and reflection (Colledge et al, 2008)
MONITORING AND REASSESSMENT
The patient should receive ongoing risk assessment and should be reassessed if there is a change 
in his/her condition. The effectiveness and suitability of the offloading, pressure redistribution 
and repositioning regimen should be reviewed.
Referral to a tissue viability service may be needed if the condition of the DTI:
■n Deteriorates rapidly or
■n Does not improve within two weeks or within a timeline defined in local policies.
DOCUMENTATION
All aspects of the patient’s management plan should be documented, along with rationale for 
each element and timing for review. The patient’s notes should be flagged to show that they 
have had a DTI because of the likely increase of increased risk for future pressure-induced 
damage.
The presence of a DTI, along with current management, should be clearly communicated to the 
receiving organisation or department if a patient is transferred or admitted elsewhere
•
•
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Prevention of DTI
Guidance from NICE does not specifically address assessment of risk for DTI, but states that an 
assessment of PU risk should be carried out and documented for adults:
■n “… being admitted to secondary care or care homes in which NHS care is provided”
■n “… receiving NHS care in other settings (such as primary and community care and emergency 
departments) if they have a risk factor” (NICE, 2014).
The 2005 NICE guidelines state that the initial assessment should be conducted within six hours 
of the first episode of care in a setting (NICE, 2005).
Healthcare Improvement Scotland’s standards for prevention and management of PUs states 
that PU risk should be assessed and documented:
■n “Within 8 hours of admission to hospital or care home
■n Within 24 hours of admission to any other care setting
■n On the first visit from community services or teams, for example, community nurse, hospital 
at home, social care or care at home” (HIS, 2016).
The NPUAP/EPUAP/PPPIA guidelines recommend that a structured risk assessment is carried 
out “as soon as possible (but within a maximum of eight hours after admission)” (NPUAP/
EPUAP/PPPIA, 2014).
ASSESSMENT OF RISK FOR DTI
Patients should be reassessed regularly and according to local policy for risk for pressure-
induced damage. Reassessment of risk should also be carried out if the patient’s condition 
changes and/or they develop an additional risk factor (Box 5 and Table 1, page 10) (NPUAP/
EPUAP/PPPIA, 2014).
Patients, families and carers should be alert to any indicators or changes that may indicate increased  
risk for DTI or pressure-induced damage and contact a healthcare professional for consideration of a 
formal assessment
Underpinning DTI prevention are:
■n Formal assessment of risk for pressure-induced damage
■n Regular skin inspections to detect early signs of pressure-induced damage, e.g. non-
blanchable erythema.
PU risk assessment tools
PU risk assessment tools for different patient groups are listed in Table 3 (page 18) and should be 
used according to local policy. Currently, there is no risk assessment tool specific to risk for DTI.
PU risk assessment tools provide a useful indication of level of risk for DTI and PUs. However, 
clinical judgement that considers all risk factors also has a very important and complementary 
role in guiding risk management (NPUAP/EPUAP/PPPIA, 2014).
Regular ‘head-to-toe’ inspection of the patient’s skin is an essential element of DTI prevention and should 
not be replaced by a PU risk assessment tool
•
•
28 | WOUNDS UK CONSENSUS DOCUMENT 2017
ASSESSMENT AND MANAGEMENT OF A PATIENT AT RISK OF DTI
The assessment and management of a patient considered at increased risk of DTI needs to 
take account of mental capacity and consent, patient preferences and the patient’s other 
needs. Figure 10, page 15, outlines the assessment and management of a patient considered at 
increased risk of DTI:
■n Holistic assessment (see pages 16-20)
■n Take action to reduce risk of tissue damage (see pages 21-26), including:
- Offload, where possible, the anatomical locations at risk of DTI
- Regular repositioning and pressure redistribution
- Optimise patient condition, including:
• Nutrition
• Pain management
• Management of comorbidities
■n Patient, family and carer education (see page 26)
■n Monitoring and reassessment, including (see page 26):
- Regular skin inspections
- Repeated PU risk assessments
- Evaluation of the effectiveness of the offloading/pressure redistribution/ 
repositioning regimen.
Patients being transferred from one facility to another may be at increased risk of DTI. The 
level of risk for a patient should be communicated clearly to the receiving facility. Appropriate 
pressure-related damage prevention measures and support surfaces should be implemented 
during transfer 
If signs of pressure-induced damage are detected, e.g. non-blanchable erythema, the patient 
and the DTI/PU prevention strategies in place should be reviewed and revised as appropriate
 
•
•
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Research needs and health 
economics
Further research is needed to establish many aspects of DTI, including incidence and the costs of 
management and prevention (Box 14).
Little is known about the health economics of DTI in the UK. However, from what is known 
of the incidence and costs of managing PUs, the socioeconomic impact of DTIs is likely to be 
considerable (Box 15).
■n Large-scale studies of the epidemiology* of DTI in the UK to 
answer questions such as:
- What is the incidence of DTI, including:
• At different anatomical locations?
• In different healthcare settings?
- What factors are associated with increased risk of DTIs and 
how do they differ from those for PUs?
- Are some risk factors for DTI more important than others?
- What proportion of DTIs:
• Resolve before the skin breaks? 
• Evolve to become open wounds?
- Are there predictors of resolution and evolution of DTIs?
■n Assessment of the quality of life impact of DTI
■n Health economic assessment of the prevention and 
management of DTIs
*The most efficient way to collect large-scale data is by using data in 
existing registries provided that reporting is comprehensive, and includes, 
for example, pressure-induced damage related to medical devices. In the 
UK, PUs and DTIs are recorded in incident reporting systems. However, 
currently, there is variation in when and how DTI is recorded. In some places, 
DTI is not reported in monitoring systems, while in others it is observed and 
only recorded when it can be assigned a pressure ulcer category (1 to 4) 
(Coleman et al, 2016). In other places, a DTI that evolves is re-categorised as 
a Category 3 or 4 PU. 
To aid consistency and data analysis, the Expert Working 
Group proposes that a DTI is recorded when first 
observed, and that it remains categorised as a DTI even if 
it resolves or evolves further with skin breakdown
■n Incidence of PUs has been estimated to be 153,000 per year in the UK (Guest et al, 2015)
■n Cost of healing a PU increases significantly with severity (from £1214 for a Category 1 PU to £14,108 for a Category 4 PU) (Dealey et 
al, 2012)
■n Using 2013/2014 prices, the cost of managing PUs in the UK was estimated to be £507–£531 billion per year (Guest et al, 2017)
■n Black JM, Brindle CT, Honaker JS (2016) Differential diagnosis of 
suspected deep tissue injury. Int Wound J 13: 531-39
■n Moore Z, Van Etten M (2014) Ten top tips: repositioning a patient 
to prevent pressure ulcers. Wounds Int 5(3): 6-9*
■n National Institute for Health and Care Excellence (NICE) (2014) 
Pressure ulcers: prevention and management. Clinical guideline CG179. 
Available at: www.nice.org
■n National Pressure Ulcer Advisory Panel (NPUAP), European 
Pressure Ulcer Advisory Panel (EPUAP) and Pan Pacific Pressure 
Injury Alliance (PPPIA) (2014) Prevention and treatment of pressure 
ulcers: quick reference guide. Cambridge Media: Osborne Park, 
Melbourne. Available at: www.epuap.org 
■n Stephens M, Bartley C (2017) Understanding the association between 
pressure ulcers and sitting in adults what does it mean for me and my 
carers? Seating guidelines for people, carers and health & social care 
professionals. J Tiss Viabil doi: 10.1016/j.jtv.2017.09.004
■n World Union of Wound Healing Societies (WUWHS) Consensus 
Document (2016) Role of dressings in pressure ulcer prevention. 
Wounds International*
■n Worsley PR, Prudden G, Gower G, Bader DL (2016) Investigating 
the effects of strap tension during non-invasive ventilation mask 
application: a combined biomechanical and biomarker approach. 
Med Devices (Auckl) 9: 409-17
■n Wounds UK (2013) Best Practice Statement. Eliminating pressure 
ulcers. London: Wounds UK**
Box 14. Research needs
Box 15. Incidence and costs of PUs
Recommended reading
*Available at: www.woundsinternational.com 
**Available at: www.wounds-uk.com
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Condition Characteristics
Calciphylaxis ■n May be excruciatingly tender and produce skin nodules or plaques; in later stages areas of painful 
necrosis produce non-healing ulcers with deep, black eschar that are often followed by infection  
and gangrene
■n Associated with chronic renal failure; rare in the general population
■n Due to vascular calcification and skin necrosis
■n Most commonly seen in the lower extremities and at adipose tissue sites rather than over  
bony prominences
Perirectal 
abscess
■n Presents with a dull aching or throbbing pain in the perineal area; pain worsens with sitting and on 
defaecation but eases after defaecation
■n May produce a tender, fluctuant mass at the anal margin
Necrotising 
fasciitis
■n Rare, severe, potentially lethal infection of the skin, soft tissues and muscles that may involve the 
abdominal wall, extremities or perineum/genitalia (Fournier’s gangrene)
■n Patients report severe pain and sometimes a history of trauma, and rapidly become unwell with sepsis
■n Skin may look pale initially, then red or bronze, and become warm and swollen. In later stages, the skin 
turns violet and develops large blisters and areas of gangrene
■n Requires rapid treatment with antibiotics and surgical debridement
Warfarin 
necrosis
■n Usually occurs within a few days of starting warfarin treatment
■n Patients are often premenopausal women being treated for deep vein thrombosis or  
pulmonary embolism
■n Affects the buttocks and thighs with paraesthesia and flushing of the skin followed by a peau d’orange 
appearance; haemorrhagic blisters develop within 24 hours
Ecthyma 
gangrenosum
■n Uncommon skin infection that may be caused by bacteria such as Pseudomonas aeruginosa or by fungi; 
reported in immunocompromised and healthy individuals; patients may develop sepsis
■n Starts with an erythematous area that develops a nodule or haemorrhagic vesicles and progresses to a 
necrotic ulcer, often containing eschar
Gluteal 
compartment 
syndrome
■n Rare; due to necrosis of the gluteal muscles following disruption of the artery (hypogastric) supplying 
blood to the muscles due to prolonged immobilisation, drug abuse, alcohol intoxication or surgery
■n Causes severe buttock pain at rest and on movement of the hip, bruising, altered sensation and 
swelling of the buttock
■n Usually requires surgical treatment
Pyoderma 
gangrenosum
■n Rare; occurs in patients with autoimmune or neoplastic diseases and most often in middle-aged adults
■n Lesions form tender papules, vesicles or pustules that evolve into painful ulcers that enlarge rapidly 
over a few days and that have raised violet-coloured (violaceous) and undermined borders
Toxic epidermal 
necrolysis/
Stevens-
Johnson 
Syndrome
■n Rare; potentially fatal
■n Causes haemorrhagic erosions, erythema, blisters and areas of denuded skin
■n Usually due to an adverse reaction to medication, but may be due to infection with Mycoplasma 
pneumoniae or Herpes simplex
Appendix 1
DISTINGUISHING DTI FROM RARE CONDITIONS THAT PRESENT WITH DISCOLOURED 
(PURPLE) SKIN +/- BROKEN SKIN (Mustafa et al, 2009; Harr & French, 2010; Misiakos et al, 2014; 
Gameiro et al, 2015; Vaiman et al, 2015; Black et al, 2016)
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